These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 15375376)

  • 21. Clinical relationship between MDR1 gene and gallbladder cancer.
    Wang BL; Zhai HY; Chen BY; Zhai SP; Yang HY; Chen XP; Zhao WT; Meng L
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):296-9. PubMed ID: 15138130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition growth of multidrug resistant KBV200 cells by MDR1 antisense RNA.
    Li Y; Wang Y
    Biochem Biophys Res Commun; 1997 Oct; 239(1):345-8. PubMed ID: 9345322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytometric study of intracellular P-gp expression and reversal of drug resistance.
    Labroille G; Belloc F; Bilhou-Nabera C; Bonnefille S; Bascans E; Boisseau MR; Bernard P; Lacombe F
    Cytometry; 1998 Jun; 32(2):86-94. PubMed ID: 9627221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1.
    Yagüe E; Higgins CF; Raguz S
    Gene Ther; 2004 Jul; 11(14):1170-4. PubMed ID: 15164094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein.
    Pichler A; Zelcer N; Prior JL; Kuil AJ; Piwnica-Worms D
    Clin Cancer Res; 2005 Jun; 11(12):4487-94. PubMed ID: 15958634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of c-myc in regulating mdr1 gene expression in tumor cell line KB.
    He Y; Zhang J; Zhang J; Yuan Y
    Chin Med J (Engl); 2000 Sep; 113(9):848-51. PubMed ID: 11776085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells.
    Dönmez Y; Gündüz U
    Biomed Pharmacother; 2011 Mar; 65(2):85-9. PubMed ID: 21237614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-MDR1 ribozymes.
    Huesker M; Folmer Y; Schneider M; Fulda C; Blum HE; Hafkemeyer P
    Hepatology; 2002 Oct; 36(4 Pt 1):874-84. PubMed ID: 12297834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug resistance induced by ouabain via the stimulation of MDR1 gene expression in human carcinomatous pulmonary cells.
    Brouillard F; Tondelier D; Edelman A; Baudouin-Legros M
    Cancer Res; 2001 Feb; 61(4):1693-8. PubMed ID: 11245485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance.
    Lage H
    Curr Drug Targets; 2006 Jul; 7(7):813-21. PubMed ID: 16842213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of MDR1 gene-dependent multidrug resistance in HL60/HT9 cells using short hairpin RNA expression vectors.
    Shao SL; Zhang WW; Li XY; Zhang ZZ; Yun DZ; Fu B; Zuo MX
    Cancer Biother Radiopharm; 2010 Apr; 25(2):171-7. PubMed ID: 20423230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms.
    Li X; Li JP; Yuan HY; Gao X; Qu XJ; Xu WF; Tang W
    Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):607-17. PubMed ID: 18193112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidrug resistance of acute leukemia and a strategy to overcome it.
    Motoji T; Motomura S; Wang YH
    Int J Hematol; 2000 Dec; 72(4):418-24. PubMed ID: 11197207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reverse multidrug resistance in laryngeal cancer cells by knockdown MDR1 gene expression.
    Zhigang H; Qi Z; Jugao F; Xiaohong C; Wei Z; Hong W; Hu H; Na M; Zheng Y; Demin H
    J Otolaryngol Head Neck Surg; 2009 Aug; 38(4):440-8. PubMed ID: 19755084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptome analysis of different multidrug-resistant gastric carcinoma cells.
    Heim S; Lage H
    In Vivo; 2005; 19(3):583-90. PubMed ID: 15875780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of P-glycoprotein but not its mRNA in multidrug resistant cells selected with hydroxyrubicin.
    Zhao JY; Savaraj N; Song R; Priebe W; Kuo MT
    Anticancer Res; 1994; 14(5A):1735-42. PubMed ID: 7531410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of differentially expressed genes in classical and atypical multidrug-resistant gastric carcinoma cells.
    Ludwig A; Dietel M; Lage H
    Anticancer Res; 2002; 22(6A):3213-21. PubMed ID: 12530067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.